|
|
|
|
| LEADER |
00000nam a2200000 i 4500 |
| 001 |
mig00004902038 |
| 003 |
OCoLC |
| 005 |
20130814093141.0 |
| 006 |
m o d f |
| 007 |
cr bn||||a|||| |
| 008 |
130814s2013 dcua ob f000 0 eng c |
| 035 |
0 |
0 |
|a ocn855764785
|
| 040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d MvI
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a TXME
|
| 050 |
1 |
4 |
|a KF27
|b .E553 2012e
|
| 074 |
|
|
|a 1019-C-01 (online)
|
| 086 |
0 |
|
|a Y 4.C 73/8:112-114
|
| 088 |
|
|
|a Serial no. 112-114 (United States. Congress. House. Committee on Energy and Commerce)
|
| 099 |
|
|
|a Online Government Document
|
| 110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Energy and Commerce.
|b Subcommittee on Health,
|e author.
|
| 245 |
1 |
0 |
|a Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages :
|b hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
|
| 264 |
|
1 |
|a Washington :
|b U.S. Government Printing Office,
|c 2013.
|
| 300 |
|
|
|a 1 online resource (iv, 194 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Title from title screen (viewed on Aug. 14, 2013).
|
| 500 |
|
|
|a Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 500 |
|
|
|a "Serial no. 112-114."
|
| 650 |
|
0 |
|a Drug approval
|z United States.
|
| 650 |
|
0 |
|a Generic drugs
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Biologicals
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Drug accessibility
|z United States.
|
| 650 |
|
0 |
|a Fees, Administrative
|z United States.
|
| 610 |
1 |
0 |
|a United States.
|b Food and Drug Administration
|x Rules and practice.
|
| 776 |
0 |
8 |
|i Print version:
|a United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
|t Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
|w (OCoLC)855764761
|
| 856 |
4 |
0 |
|z CONNECT
|u http://purl.fdlp.gov/GPO/gpo39088
|t 0
|
| 907 |
|
|
|a 2279544
|b 06-10-21
|c 03-14-14
|
| 998 |
|
|
|a wi
|b 03-14-14
|c m
|d z
|e -
|f eng
|g dcu
|h 0
|i 1
|
| 910 |
|
|
|a MTSUM139
|
| 910 |
|
|
|a DWS
|
| 999 |
f |
f |
|i 7b86ef05-1863-4df0-912d-7b6ab06ec579
|s 0dfffb9a-48f6-4062-8bf2-14a2fe7df4ef
|t 0
|
| 952 |
f |
f |
|a Middle Tennessee State University
|b Main
|c James E. Walker Library
|d Electronic Resources
|t 0
|e Y 4.C 73/8:112-114
|h Library of Congress classification
|
| 856 |
4 |
0 |
|t 0
|u http://purl.fdlp.gov/GPO/gpo39088
|z CONNECT
|
